Related Experiment Videos
Sources of variability in normal CA 125 levels
1Department of Obstetrics and Gynecology, School of Public Health, Columbia University College of Physicians & Surgeons, New York, New York 10032.
Summary
Single measurements of CA 125 (cancer antigen 125) in asymptomatic menopausal women are reliable, even at low levels. This tumor marker variability study suggests lower thresholds for ovarian cancer screening.
Area of Science:
- Oncology
- Clinical Chemistry
- Biostatistics
Background:
- CA 125 (cancer antigen 125) is a tumor marker often used in ovarian cancer screening.
- Understanding variability in CA 125 measurements is crucial for accurate interpretation, especially at low levels.
- Previous studies have focused on higher CA 125 levels, leaving a gap in knowledge regarding low-level variability.
Purpose of the Study:
- To quantify biological and assay variability of CA 125 at low concentrations.
- To assess the reliability of single, low CA 125 measurements in asymptomatic menopausal women.
- To inform the development of ovarian cancer screening protocols using CA 125.
Main Methods:
- Analysis of 288 serum specimens from 144 asymptomatic menopausal women, with each specimen assayed twice.
- Random assignment of specimens to 16 different CA 125 assay kits.
- Focus on subjects with CA 125 values below 35 units/ml.
Main Results:
- The total error from all sources (biological and assay variability) was approximately 13% of observed values.
- Low-level CA 125 measurements demonstrated acceptable reliability.
- Findings indicate that a single low CA 125 value can be a trustworthy indicator of a woman's true level.
Conclusions:
- Single, low CA 125 values are reliable indicators of a woman's true CA 125 level.
- Clinical trials for ovarian cancer screening should consider CA 125 thresholds below the conventional 35 units/ml.
- Further research into the performance of CA 125 at lower detection limits is warranted for improved screening efficacy.